As of 2025-02-17, the Relative Valuation of Inovio Pharmaceuticals Inc (INO) is (80.24) USD. This relative valuation is based on P/E multiples. With the latest stock price at 2.15 USD, the upside of Inovio Pharmaceuticals Inc based on Relative Valuation is -3831.9%.
The range of the Relative Valuation is (65.75) - (89.93) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
Range | Selected | |
Trailing P/E multiples | 21.0x - 33.9x | 27.4x |
Forward P/E multiples | 18.9x - 28.7x | 23.8x |
Fair Price | (65.75) - (89.93) | (80.24) |
Upside | -3158.3% - -4282.6% | -3831.9% |
Date | P/E |
2025-02-14 | -0.69 |
2025-02-13 | -0.68 |
2025-02-12 | -0.68 |
2025-02-11 | -0.61 |
2025-02-10 | -0.61 |
2025-02-07 | -0.63 |
2025-02-06 | -0.64 |
2025-02-05 | -0.65 |
2025-02-04 | -0.63 |
2025-02-03 | -0.64 |
2025-01-31 | -0.67 |
2025-01-30 | -0.67 |
2025-01-29 | -0.65 |
2025-01-28 | -0.70 |
2025-01-27 | -0.72 |
2025-01-24 | -0.70 |
2025-01-23 | -0.73 |
2025-01-22 | -0.72 |
2025-01-21 | -0.70 |
2025-01-17 | -0.66 |
2025-01-16 | -0.61 |
2025-01-15 | -0.59 |
2025-01-14 | -0.60 |
2025-01-13 | -0.61 |
2025-01-10 | -0.63 |
2025-01-08 | -0.67 |
2025-01-07 | -0.73 |
2025-01-06 | -0.62 |
2025-01-03 | -0.63 |
2025-01-02 | -0.58 |
2024-12-31 | -0.58 |
2024-12-30 | -0.57 |
2024-12-27 | -0.60 |
2024-12-26 | -0.59 |
2024-12-24 | -0.58 |
2024-12-23 | -0.57 |
2024-12-20 | -0.59 |
2024-12-19 | -0.59 |
2024-12-18 | -0.57 |
2024-12-17 | -0.63 |
2024-12-16 | -0.69 |
2024-12-13 | -0.74 |
2024-12-12 | -1.20 |
2024-12-11 | -1.29 |
2024-12-10 | -1.29 |
2024-12-09 | -1.32 |
2024-12-06 | -1.33 |
2024-12-05 | -1.28 |
2024-12-04 | -1.32 |
2024-12-03 | -1.34 |